Healing Infrastructure: Kedaara Capital Pours $200M Into Tynor Orthotics

Private equity firm Kedaara Capital has announced a strategic investment of $200 million in Indian medical-technology brand Tynor Orthotics.

Expanding India’s Medical Device Footprint

MUMBAI / MOHALI — In a major transaction within India's healthcare sector, private equity firm Kedaara Capital has committed $200 million to Tynor Orthotics Private Limited, a prominent manufacturer of orthopedic supports, fracture aids, and rehabilitation solutions. The announcement marks a critical milestone for the homegrown medical-technology brand as it seeks to scale its production capacity and deepen its global market presence.

Founded in 1993, Tynor has grown into an industry leader specializing in more than 150 healthcare products, including body braces, advanced knee supports, walking aids, and silicone foot-care solutions. Operating out of extensive manufacturing facilities in Mohali spanning over 650,000 square feet, the company utilizes lean manufacturing frameworks to supply products domestically and across 60 international countries.

Strategic Growth and Global Scaling

The infusion of capital will primarily target the enhancement of Tynor's infrastructure and manufacturing capabilities. According to corporate statements, Kedaara Capital will collaborate closely with Tynor's promoters, Dr. P.J. Singh and A.J. Singh, along with existing strategic partners like Thuasne, to build a comprehensive global wellness and orthotics platform.

Industry analysts note that India’s medical device sector is experiencing rapid expansion, driven by rising health insurance penetration, improved affordability, and a growing patient base. By securing institutional backing from Kedaara Capital, Tynor aims to position itself as a key supply-chain provider for markets across the Global North while cementing its leadership across the Global South.

Official Sources Section

According to official company statements and regulatory disclosures released by Kedaara Capital and Tynor Orthotics, the transaction involves structured equity funding to support long-term operational scaling. Financial tracking and corporate updates have been documented via industry news portals and market reports by Fortune India and financial analytics platforms tracking the Indian private equity landscape.

Quote Section

"According to officials, the partnership will focus on strengthening manufacturing capabilities and building Tynor into a global orthotics and wellness platform serving both domestic and international markets."

Why It Matters

For consumers, healthcare providers, and patients, this capital injection ensures wider access to high-quality, affordable orthopedic devices and rehabilitation solutions. For the broader Indian medical-technology ecosystem, the investment highlights growing investor confidence in domestic manufacturing capabilities, paving the way for advanced healthcare infrastructure development in tier-2 and tier-3 cities.

Key Facts at a Glance

• Investment Amount: $200 million strategic capital injection by Kedaara Capital.

• Target Company: Tynor Orthotics Private Limited.

• Core Offerings: Over 150 items including orthopedic supports, mobility aids, and rehabilitation devices.

• Global Footprint: Distribution network spanning more than 300,000 retail outlets and 8,000 hospitals across 60 countries.

FAQ Section

What is the primary purpose of Kedaara Capital's investment in Tynor?

The $200 million investment is designed to expand Tynor's manufacturing capabilities, scale its product portfolio, and strengthen its distribution footprint in India and international markets.

What products does Tynor Orthotics manufacture?

Tynor produces over 150 healthcare items, including orthopedic body braces, fracture and walking aids, advanced knee supports, and rehabilitation solutions.

Who are the key stakeholders involved in the partnership?

The collaboration involves Kedaara Capital, Tynor promoters Dr. P.J. Singh and A.J. Singh, the professional management team, and strategic partner Thuasne.

How extensive is Tynor's current market reach?

Tynor distributes its products through more than 300,000 retail outlets and 8,000 hospitals across 60 countries, having reached over 100 million patients.

Source: Fortune India Business News, Kedaara Capital Corporate Releases